Analyst Ratings for Kailera Therapeutics (KLRA)
KLRA Rating Summary
KLRA Price Target Summary
- Highest: $57.00 (TD Cowen)
- Lowest: $30.00 (JPMorgan)
- Average: $42.75
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$42.75 (+97.8%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/12/2026 | Evercore ISI | Umer Raffat | New Coverage | Outperform (N/A) |
N/A (N/A) |
22.93 (21.61) |
-5.76% | Details |
| 5/12/2026 | Leerink | David R | New Coverage | Outperform (N/A) |
36.00 (N/A) |
22.93 (21.61) |
-5.76% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


